🔎 Trials Near Me

Avaleht › Atoopiline dermatiit (ekseem) › Missouri

Atoopiline dermatiit (ekseem) kliinilised uuringud osariigis Missouri

7 uuringut haiguse Atoopiline dermatiit (ekseem) jaoks otsivad osalejaid osariigis Missouri.

Ametlik uuringutekst (inglise keeles)

This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

  • Red River Research Partners, Llc- Site Number : 8400054, Bolivar
  • Cleaver Dermatology- Site Number : 8400033, Kirksville
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07290803

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  • Novartis Investigative Site, Saint Joseph
VärbamineFaas 2
Vanused 18–100 · Kõik sood · Uuendatud 28. sept 2026 · NCT06947993

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

  • Saint Louis University, St Louis
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 25. sept 2026 · NCT06807281

Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

  • U.S. Dermatology Partners Lee's Summit, Lee's Summit
VärbamineVaatlusuuring
Vanused 12–89 · Kõik sood · Uuendatud 15. sept 2026 · NCT07645820

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

  • Washington University School of Medicine - St. Louis /ID# 268545, St Louis
VärbamineFaas 3
Vanused 2–11 · Kõik sood · Uuendatud 6. aug 2026 · NCT06461897

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

  • MediSearch Clinical Trials /ID# 263579, Saint Joseph
VärbamineFaas 3
Vanused 18–63 · Kõik sood · Uuendatud 6. juuli 2026 · NCT06389136

Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

  • Galderma Investigational Site 7057, Lee's Summit
VärbamineVaatlusuuring
Vanused 12 ja vanemad · Kõik sood · Uuendatud 13. märts 2026 · NCT06988605

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.